MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

BACKGROUND: Fludarabine, is one of the most active single agents in the treatment of chronic lymphocytic leukemia (CLL). Over time, however, virtually all CLL patients become fludarabine-refractory. To elucidate whether microRNAs are involved in the development of fludarabine resistance, we analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferracin, Manuela, Zagatti, Barbara, Rizzotto, Lara, Cavazzini, Francesco, Veronese, Angelo, Ciccone, Maria, Saccenti, Elena, Lupini, Laura, Grilli, Andrea, De Angeli, Cristiano, Negrini, Massimo, Cuneo, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892453/
https://www.ncbi.nlm.nih.gov/pubmed/20504344
http://dx.doi.org/10.1186/1476-4598-9-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892453/
https://www.ncbi.nlm.nih.gov/pubmed/20504344
http://dx.doi.org/10.1186/1476-4598-9-123

Ejemplares similares